Format
Items per page
Sort by

Send to:

Choose Destination

Results: 9

1.

Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.

Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, Montgomery J, Nizam A, Lane BF, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Lynch JR, Zaidat OO, Rumboldt Z, Cloft HJ; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators.

Lancet. 2014 Jan 25;383(9914):333-41. doi: 10.1016/S0140-6736(13)62038-3. Epub 2013 Oct 26.

2.

Gender based differences in acute stroke care in Michigan hospitals.

Nagaraja N, Bhattacharya P, Mada F, Salowich-Palm L, Hinton S, Millis S, Watson SR, Chaturvedi S, Rajamani K.

J Neurol Sci. 2012 Mar 15;314(1-2):88-91. doi: 10.1016/j.jns.2011.10.022. Epub 2011 Dec 7.

PMID:
22154189
3.

Are racial disparities in stroke care still prevalent in certified stroke centers?

Bhattacharya P, Mada F, Salowich-Palm L, Hinton S, Millis S, Watson SR, Chaturvedi S, Rajamani K.

J Stroke Cerebrovasc Dis. 2013 May;22(4):383-8. doi: 10.1016/j.jstrokecerebrovasdis.2011.09.018. Epub 2011 Nov 10.

PMID:
22078781
4.

Thrombolysis for acute ischemic stroke in Joint Commission-certified and -noncertified hospitals in Michigan.

Rajamani K, Millis S, Watson S, Mada F, Salowich-Palm L, Hinton S, Chaturvedi S.

J Stroke Cerebrovasc Dis. 2013 Jan;22(1):49-54. doi: 10.1016/j.jstrokecerebrovasdis.2011.06.003.

PMID:
21852156
5.

Anticardiolipin antibodies and mortality in patients with ischemic stroke: a prospective follow-up study.

Tanne D, D'Olhaberriague L, Trivedi AM, Salowich-Palm L, Schultz LR, Levine SR.

Neuroepidemiology. 2002 Mar-Apr;21(2):93-9.

PMID:
11901279
6.

Anticardiolipin antibodies and their associations with cerebrovascular risk factors.

Tanne D, D'Olhaberriague L, Schultz LR, Salowich-Palm L, Sawaya KL, Levine SR.

Neurology. 1999 Apr 22;52(7):1368-73.

PMID:
10227619
7.

Specificity, isotype, and titer distribution of anticardiolipin antibodies in CNS diseases.

D'Olhaberriague L, Levine SR, Salowich-Palm L, Tanne D, Sawaya KL, Aurora TK, Perry M, Day M, Spencer T, Schultz L.

Neurology. 1998 Nov;51(5):1376-80.

PMID:
9818863
8.

IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study.

Levine SR, Salowich-Palm L, Sawaya KL, Perry M, Spencer HJ, Winkler HJ, Alam Z, Carey JL.

Stroke. 1997 Sep;28(9):1660-5.

9.

Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome.

Levine SR, Brey RL, Sawaya KL, Salowich-Palm L, Kokkinos J, Kostrzema B, Perry M, Havstad S, Carey J.

Ann Neurol. 1995 Jul;38(1):119-24.

PMID:
7611714
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk